- Honduran helicopter crash kills six, including president's sister
- Brazil's Workers Party formalizes support for ex-president Lula
- Foreign minister warns UK cannot become 'vassal state' of EU
- More than half of Britons now want to stay in EU - poll
- An update on winners and losers on the U.S. tax scorecard
- Uber accused of espionage, hacking and bribery in bombshell letter
- Christian Bale and more to salute CNN Heroes
- Destiny 2 Xur Location Guide: Where Is Xur, What Is He Selling? (December 15-18)
- More than half of Britons now want to stay in EU: poll
- Mudslide in southern Chile kills three; 15 others missing
- Odebrecht says dealings with Peru president were legitimate
- U.N. council mulls call for U.S. Jerusalem decision to be withdrawn
- Tillerson confronts North Korea at UN
- Elysee plays down opulence of Macron birthday at Loire chateau
- Argentina fires head of navy over submarine tragedy
- Egyptian presidential hopeful apologizes to arrested supporters
- Argentina fires head of navy after submarine tragedy
- Canadian police probe mysterious deaths of billionaire pharma couple
- Nazareth Christmas celebrations will be held as normal: mayor
- Libyan coast guard rescues more than 250 migrants trying to reach Ital
Australia competition watchdog takes GlaxoSmithKline, Novartis units to court
(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.
The ACCC alleged that the companies tried to market their two pain relief products, Osteo Gel and Emulgel, as having different levels of impact in treating osteoarthritis, when in fact they are “identically formulated”.
”We allege that consumers are likely to have been misled into purchasing Osteo Gel thinking that it is different to Emulgel and more effective for treating osteoarthritis conditions, when this is not the case”, ACCC Chairman Rod Sims said.
Reporting by Susan Mathew in Bengaluru
Our Standards:The Thomson Reuters Trust Principles.